FDA: Naproxen No Safer for Heart Than Other Pain Relievers

Tuesday, 11 Feb 2014 04:20 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products.

The panel was convened after a retrospective analysis from multiple clinical trials published last year in The Lancet suggested naproxen was less dangerous to the heart than other nonsteroidal anti-inflammatory drugs, or NSAIDs, such as ibuprofen and Celebrex.

Panelists recommended the FDA leave the current product labeling as is, at least pending the outcome of a large ongoing study, known as Precision, that compares naproxen with ibuprofen and Celebrex. The FDA is not bound to follow the advice of its advisory panels, but typically does so.

The FDA's final decision could have wide implications for the way in which these drugs are prescribed and used in the future, and it will have implications for whether the Precision trial is able to continue.

The panel voted 16-9 that while the retrospective combining of results from different studies, known as meta-analysis, hints at a relative benefit for naproxen over other NSAIDs, the data is not reliable and does not warrant changing the prescribing information to reflect a differentiated risk.

"Meta-analyses are good for raising questions but not settling them," said panelist Dr. Sanjay Kaul, a cardiologist and professor at UCLA School of Medicine.

Naprosyn is a prescription product sold by Roche Holding AG, while Aleve is sold over the counter by Bayer AG. Ibuprofen is marketed as Advil by Pfizer Inc and Motrin by Johnson & Johnson. Celebrex is a prescription product made by Pfizer.

Over-the-counter generic versions of both naproxen and ibuprofen are also available.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

US Missionary Doctor in Liberia Contracts Ebola

Tuesday, 02 Sep 2014 17:33 PM

An American doctor working in Liberia has tested positive for the Ebola virus after working with obstetrics patients at  . . .

Double Mastectomy Doesn't Boost Breast Cancer Survival

Tuesday, 02 Sep 2014 17:25 PM

Removing both breasts to treat cancer affecting only one side doesn't boost survival chances for most women, compared wi . . .

Ebola 'Spiraling Out of Control': CDC Chief

Tuesday, 02 Sep 2014 15:14 PM

The CDC director says that the Ebola outbreak is spiraling out of control and is likely to get worse. . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved